{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:54:34Z","timestamp":1788317674842,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"am","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ando.2024.01.006","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T16:52:46Z","timestamp":1705683166000},"page":"136-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Amiodarone-induced thyrotoxicosis: Should surgery be considered?"],"prefix":"10.1016","volume":"85","author":[{"given":"Samuel","family":"Frey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Caillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Mahot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Drui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Miralli\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2024.01.006_bib0185","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/thy.1997.7.541","article-title":"Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis","volume":"7","author":"Bogazzi","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2024.01.006_bib0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000486957","article-title":"2018 European Thyroid Association (ETA) Guidelines for the management of amiodarone-associated thyroid dysfunction","volume":"7","author":"Bartalena","year":"2018","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.ando.2024.01.006_bib0195","first-page":"240","article-title":"The effects of amiodarone on the thyroid","volume":"22","author":"Martino","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2024.01.006_bib0200","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2265.2008.03350.x","article-title":"Benzofuran derivatives and the thyroid","volume":"70","author":"Han","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2024.01.006_bib0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/europace\/euac217","article-title":"Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study","volume":"25","author":"Ali","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.ando.2024.01.006_bib0210","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.3390\/jcm11072027","article-title":"Thyroid dysfunction under amiodarone in patients with and without congenital heart disease: results of a nationwide analysis","volume":"11","author":"Fischer","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ando.2024.01.006_bib0215","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-9343(91)90187-3","article-title":"Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism","volume":"91","author":"Trip","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2024.01.006_bib0220","doi-asserted-by":"crossref","first-page":"e000392","DOI":"10.1136\/bmjmed-2022-000392","article-title":"Changes in medication safety indicators in England throughout the covid-19 pandemic using OpenSAFELY: population based, retrospective cohort study of 57 million patients using federated analytics","volume":"2","author":"Fisher","year":"2023","journal-title":"BMJ Med"},{"key":"10.1016\/j.ando.2024.01.006_bib0225","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/BF03347002","article-title":"Diagnosis of amiodarone-iodine-induced thyrotoxicosis (AIIT) associated with severe nonthyroidal illness","volume":"10","author":"Balzano","year":"1987","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2024.01.006_bib0230","first-page":"1463","article-title":"Identification of two different phenotypes of patients with amiodarone-induced thyrotoxicosis and positive thyrotropin receptor antibody tests","volume":"31","author":"Cappellani","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2024.01.006_bib0235","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1210\/jc.2010-0180","article-title":"Approach to the patient with amiodarone-induced thyrotoxicosis","volume":"95","author":"Bogazzi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.006_bib0240","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1210\/jc.2008-1907","article-title":"Amiodarone-induced thyrotoxicosis is a predictor of adverse cardiovascular outcome","volume":"94","author":"Yiu","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.006_bib0245","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2007.02.054","article-title":"Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome","volume":"49","author":"Conen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ando.2024.01.006_bib0250","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/eje.1.02122","article-title":"Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality","volume":"154","author":"O'Sullivan","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2024.01.006_bib0255","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1210\/jc.2011-2390","article-title":"Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial","volume":"97","author":"Eskes","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.006_bib0260","doi-asserted-by":"crossref","first-page":"dgaa464","DOI":"10.1210\/clinem\/dgaa464","article-title":"Duration of exposure to thyrotoxicosis increases mortality of compromised ait patients: the role of early thyroidectomy","volume":"105","author":"Cappellani","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.006_bib0265","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2024.01.006_bib0270","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1089\/thy.2018.0320","article-title":"Duration of hyperthyroidism and lack of sufficient treatment are associated with increased cardiovascular risk","volume":"29","author":"Lillevang-Johansen","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2024.01.006_bib0275","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1210\/clinem\/dgac756","article-title":"Real-life data on the effect of medical therapy for amiodarone-induced thyrotoxicosis on CV events and hospitalizations","volume":"108","author":"Cappellani","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.006_bib0280","doi-asserted-by":"crossref","first-page":"dgz041","DOI":"10.1210\/clinem\/dgz041","article-title":"Comparison between total thyroidectomy and medical therapy for amiodarone-induced thyrotoxicosis","volume":"105","author":"Cappellani","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.006_bib0285","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1210\/jc.2012-1797","article-title":"Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction","volume":"97","author":"Tomisti","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2024.01.006_bib0290","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1210\/js.2018-00259","article-title":"Thyroidectomy for amiodarone-induced thyrotoxicosis: Mayo Clinic experience","volume":"2","author":"Kotwal","year":"2018","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.ando.2024.01.006_bib0295","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.anorl.2014.04.005","article-title":"Surgical management of hyperthyroidism","volume":"132","author":"Qu\u00e9rat","year":"2015","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"10.1016\/j.ando.2024.01.006_bib0300","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00268-004-7599-6","article-title":"Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience","volume":"28","author":"Houghton","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2024.01.006_bib0305","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/ohn.405","article-title":"Mortality after total thyroidectomy for amiodarone-induced thyrotoxicosis according to left ventricular ejection fraction","volume":"169","author":"Frey","year":"2023","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ando.2024.01.006_bib0310","doi-asserted-by":"crossref","DOI":"10.1007\/s40618-023-02168-3","article-title":"Short review: novel concepts in the approach to patients with amiodarone-induced thyrotoxicosis","author":"Cappellani","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2024.01.006_bib0315","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/bjs5.2","volume":"1","author":"Blanchard","year":"2017","journal-title":"BJS Open"},{"key":"10.1016\/j.ando.2024.01.006_bib0350","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/PL00024613","article-title":"Surgical management of amiodarone-associated thyrotoxicosis: too risky or too effective?","volume":"22","author":"Hamoir","year":"1998","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2024.01.006_bib0355","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00268-005-0673-x","article-title":"Total thyroidectomy for amiodarone-associated thyrotoxicosis in patients with severe cardiac disease","volume":"30","author":"Gough","year":"2006","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2024.01.006_bib0360","first-page":"45","article-title":"Total thyroidectomy for amiodarone-induced thyrotoxicosis in the hyperthyroid state","volume":"124","author":"Kaderli","year":"2016","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ando.2024.01.006_bib0320","first-page":"86","article-title":"Therapeutic plasma exchange in refractory hyperthyroidism","volume":"10","author":"Sa\u00efe","year":"2021","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.ando.2024.01.006_bib0325","doi-asserted-by":"crossref","first-page":"e529","DOI":"10.7861\/clinmed.2021-0482","article-title":"Resistant type 2 amiodarone-induced thyrotoxicosis responsive to cholestyramine as an adjunctive therapy","volume":"21","author":"Rummaan","year":"2021","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.ando.2024.01.006_bib0330","doi-asserted-by":"crossref","first-page":"5794054","DOI":"10.1155\/2018\/5794054","article-title":"Nonthionamide drugs for the treatment of hyperthyroidism: from present to future","volume":"2018","author":"Suwansaksri","year":"2018","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.ando.2024.01.006_bib0335","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-9343(97)00047-8","article-title":"Lithium treatment in amiodarone-induced thyrotoxicosis","volume":"102","author":"Dickstein","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2024.01.006_bib0340","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/105072502760143926","article-title":"Thyroidectomy using local anesthesia in critically ill patients with amiodarone-induced thyrotoxicosis: a review and description of the technique","volume":"12","author":"Williams","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.ando.2024.01.006_bib0345","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijscr.2020.05.078","article-title":"Hypnosis and superficial cervical anesthesia for total thyroidectomy in a high-risk patient\u00a0\u2013\u00a0a case report","volume":"72","author":"Makovac","year":"2020","journal-title":"Int J Surg Case Rep"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426624000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426624000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T14:42:08Z","timestamp":1713192128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426624000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0003426624000064"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2024.01.006","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amiodarone-induced thyrotoxicosis: Should surgery be considered?","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2024.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}